For example, a significant therapeutic effect has been proven in the treatment of human cancers using PD-L1 inhibitors, which target the immune checkpoint, and miR-34a is a natural inhibitor of PD-L1 [10, 11]. This evidence concerns the gene CD274 and cancer.